Benzinga | Feb 25, 2021 07:16AM EST

Chimerix Q4 EPS $(0.19) Beats $(0.20) Estimate, Sales $1.10M Beat $1.03M Estimate

Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. This is a 216.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $1.10 million which beat the analyst consensus estimate of $1.03 million by 6.80 percent. This is a 83.74 percent decrease over sales of $6.77 million the same period last year.